|
SLC20A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.19320000002698E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.630320E-04 |
| Normal-vs-Stage2 |
9.506800E-01 |
| Normal-vs-Stage3 |
3.281800E-03 |
| Normal-vs-Stage4 |
4.952600E-04 |
| Stage1-vs-Stage2 |
1.165590E-02 |
| Stage1-vs-Stage3 |
5.563700E-02 |
| Stage1-vs-Stage4 |
1.344390E-02 |
| Stage2-vs-Stage3 |
3.962600E-03 |
| Stage2-vs-Stage4 |
6.363200E-04 |
| Stage3-vs-Stage4 |
7.430000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.95210000012381E-07 |
| Normal-vs-AfricanAmerican |
3.876400E-02 |
| Normal-vs-Asian |
4.443900E-02 |
| Caucasian-vs-AfricanAmerican |
7.758200E-01 |
| Caucasian-vs-Asian |
3.341500E-03 |
| AfricanAmerican-vs-Asian |
2.049400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.924600E-03 |
| Normal-vs-Female |
1.66899999998193E-06 |
| Male-vs-Female |
3.649000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.68399999999069E-05 |
| Normal-vs-Age(41-60Yrs) |
7.161500E-03 |
| Normal-vs-Age(61-80Yrs) |
2.099900E-03 |
| Normal-vs-Age(81-100Yrs) |
7.822200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.774000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.067200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.829350E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.824800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.658000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.636200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.568500E-02 |
| Classical-VS-Follicular |
1.62481139653892E-12 |
| Classical-VS-Other |
1.231780E-02 |
| Classical-VS-Normal |
5.0828000031089E-08 |
| Tall-VS-Follicular |
5.14899999970453E-07 |
| Tall-VS-Other |
1.518690E-03 |
| Tall-VS-Normal |
4.11369999999689E-05 |
| Follicular-VS-Other |
1.083280E-03 |
| Follicular-VS-Normal |
4.646300E-04 |
| Other-VS-Normal |
3.134800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.940100E-02 |
| Normal-vs-N1 |
1.156800E-04 |
| N0-vs-N1 |
1.076220E-03 |
|
|
